Skip to main content

Month: August 2021

Altera Infrastructure GP L.L.C. Announces Extension of Early Participation Deadline for Exchange Offer and Consent Solicitation

ABERDEEN, United Kingdom, Aug. 12, 2021 (GLOBE NEWSWIRE) — Altera Infrastructure GP L.L.C., the general partner of Altera Infrastructure L.P. (“Altera” or the “Partnership”), today announced that it is extending the Early Tender Time (as defined in the Offering Memorandum (as defined below)) to 5:00 p.m., New York City time, on August 16, 2021, for the offer (the “Exchange Offer”) by Altera Infrastructure Holdings L.L.C., a wholly owned subsidiary of the Partnership (“Holdings”), to exchange the 8.50% Senior Notes due 2023 (the “Old Notes”) issued by the Partnership and Altera Infrastructure Finance Corp. for newly issued 8.50% Senior Secured Notes due 2026 or 11.50% Senior Secured PIK Notes due 2026 issued by Holdings. The withdrawal deadline has expired and will not be extended. The Exchange Offer will expire at 11:59 p.m., New...

Continue reading

Enedo Plc publishes Half Year Financial Report January 1 – June 30, 2021 and removes financial estimate

ENEDO PLC   Half year financial report August 12th, 2021   at 9.45 a.m. ENEDO PLC PUBLISHES HALF YEAR FINANCIAL REPORT JANUARY 1 – JUNE 30, 2021 AND REMOVES FINANCIAL ESTIMATE January – June 2021 in brief, Continuing operations– Net sales EUR 18,1 million (EUR 19,7 million)– Operating profit        EUR -2,9 million (EUR -1,9 million)– Adjusted operating profit EUR -2,3 million (EUR -1,7 million)– EBITDA EUR -1,2 million (EUR -0,1 million)– Adjusted EBITDA EUR -0,6 million (EUR 0,1 million)– Profit/loss for the period, continuing operations EUR -0,4 million (EUR -2,4 million)*– Earnings per share EUR -0,01 (EUR -0,28) The figures in the release are presented from continuing operations unless otherwise noted.  1-6/2021 1-6/20 1-12/20Key indicators, EUR million 6mo 6mo 12moContinuing operations:      Net...

Continue reading

Ex-date for exercising pre-emptive right to subscribe for new shares

On 02.08.2021, Aktsiaselts Tallink Grupp informed of its intention to increase share capital, conduct a public offering and fix the list of shareholders entitled to exercise pre-emptive right to subscribe for new shares. The respective news is available here. The list of the shareholders entitled to exercise the pre-emptive right to subscribe for the new shares shall be fixed at the end of the business day on 17.08.2021 (the record date). Therefore, the ex-date (the date of changing the rights attached to shares), i.e. the date as of which the shares are traded without pre-emptive subscription right, is 16.08.2021. Joonas JoostFinancial Director AS Tallink GruppSadama 510111 TallinnE-mail joonas.joost@tallink.ee

Continue reading

Ex-date for exercising pre-emptive right to subscribe for new shares

On 02.08.2021, Aktsiaselts Tallink Grupp informed of its intention to increase share capital, conduct a public offering and fix the list of shareholders entitled to exercise pre-emptive right to subscribe for new shares. The respective news is available here. The list of the shareholders entitled to exercise the pre-emptive right to subscribe for the new shares shall be fixed at the end of the business day on 17.08.2021 (the record date). Therefore, the ex-date (the date of changing the rights attached to shares), i.e. the date as of which the shares are traded without pre-emptive subscription right, is 16.08.2021. Joonas JoostFinancial Director AS Tallink GruppSadama 510111 TallinnE-mail joonas.joost@tallink.ee

Continue reading

Anoto Group AB (publ) bring forward the release of the interim report for January – June 2021

Anoto Group AB (publ) has decided to bring forward the release of the interim report for January – June 2021. The new date for the release is Friday, August 20, 2021. The previously announced date for the release was Tuesday, August 31, 2021. For further information, please contact: Perry Ha, CEO, Anoto Group AB For more information about Anoto, please visit www.anoto.com or email ir@anoto.com Anoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, 116 74 Stockholm About Anoto Group Anoto is a publicly held Swedish technology company known globally for innovation in the area of information-rich patterns and the optical recognition of those patterns. It is a leader in digital writing and drawing solutions, having historically used its proprietary technology to develop smartpens and the related software. These smartpens enrich the daily...

Continue reading

Invalda INVL establishes INVL Life which will seek an insurance company licence

The asset management group Invalda INVL, in preparation for carrying out a transaction to acquire the Baltic business of Mandatum Life, one of Finland’s largest life insurance companies, has established a new company, INVL Life, which in the near future will apply to the Bank of Lithuania for an insurance company licence. The new company is led by Rasa Kasperavičiūtė. While Rasa Kasperavičiūtė‘s main position remains the manager of Mandatum Life branch until Lithuanian insurance portfolio transfer to the new company is completed. Rasa Kasperavičiūtė will also be the new company’s chairwoman of the board. Serving on the board with her will be Vytenis Lazauskas, the chief financial officer of INVL Asset Management, and long-time INVL Asset Management employee Martynas Samulionis who is managing partner of the INVL Sustainable Timberland...

Continue reading

Novozymes delivers strong Q2 results and narrows full-year guidance to the high-end of the range

Novozymes delivered 9% organic sales growth in the second quarter and 6% organic sales growth in the first half of 2021. The company has narrowed its full-year financial guidance from previously 2-6% and now expects organic sales growth of 4-6% and an EBIT margin of ~26%, from previously 25-26%. COPENHAGEN, Denmark – August 12, 2021. With 9% organic sales growth in Q2 and 6% organic sales growth in the first six months, Novozymes takes another important step in fulfilling its long-term growth strategy although uncertainties related to the pandemic remains. In the first half year, Novozymes delivers an EBIT-margin of 28.6% and ROIC including goodwill is 22.2%. “Our results for the first half of the year are strong and we continue to deliver on our strategy, Better Business with Biology. Novozymes is built for growth and we are very pleased...

Continue reading

BW Energy: Invitation to Q2 2021 Presentation 20 August

Invitation to Q2 2021 Presentation 20 August BW Energy will release its Half-Year 2021 results on Friday 20 August at 07:30 CEST. A conference call followed by Q&A will be hosted by CEO Carl K. Arnet, CFO Knut R. Sæthre and COO Lin G. Espey the same day at 14:00 CEST. Conference call information: To dial in to the conference call where the second quarter results and Q&A will be hosted, please dial in to one of the following numbers: Norway: +47 2396 3688France: +33 170 750 736Singapore: +65 6408 5768UK: +44 3333 009 262US: +1 6467 224 903 You can also follow the presentation via webcast with supporting slides, available on: https://streams.eventcdn.net/bwe/q2-2021/ Please note, that if you follow the webcast via the above URL, you will experience a 30 second delay compared to the main conference call. The web page works best...

Continue reading

Wolters Kluwer nominates Heleen Kersten for appointment to Supervisory Board

Wolters Kluwer nominates Heleen Kersten for appointment to Supervisory Board August 12, 2021, Wolters Kluwer today announced the nomination of Heleen Kersten for appointment to its Supervisory Board. The nomination will be submitted to the Wolters Kluwer Annual General Meeting of Shareholders on April 21, 2022. Ms. Kersten is a partner at law firm Stibbe. She specializes in mergers and acquisitions, equity capital markets, corporate law and corporate governance. She started practicing in 1989 with Stibbe, before joining Davis Polk in New York and London. In 1993, she returned to Stibbe Amsterdam and has practiced there ever since. Ms. Kersten became a partner in 1997. From 2008 to 2013, she was managing partner of Stibbe Amsterdam, whilst remaining active in her areas of specialism. Ms. Kersten is Chairman of the Dutch Red Cross and Vice-Chairman...

Continue reading

ContextVision: Best ever sales within Medical Imaging and rewarding feedback from INIFY Prostate evaluations

STOCKHOLM – August 12, 2021 – ContextVision, a medical technology software company specializing in image processing, delivered the Company’s best ever second quarter within Medical Imaging. Initial response from the ongoing clinical trials with the Company’s first digital pathology product, INIFY Prostate, are very promising. Sales in the second quarter reached 24.4 MSEK (20,1), an 20% increase compared with the previous quarter, and an increase of 32% versus last year’s corresponding quarter when adjusted for currency exchange effects. Impressive accuracy – is the feedback from evaluations sites within digital pathology“INIFY Prostate delivered impressive accuracy in it’s ongoing clinical evaluations. In the second quarter we expanded into the US getting two prestigious medical sites onboard for clinical testing”, says CEO...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.